This website uses first-party and third-party cookies to offer you a better user experience and service. By continuing to browse our website or use our services, you agree to the use of cookies. You may change your cookie settings at any time.


Abac Solutions acquires PronoKal Group

SOURCE: Private Equity Wire

Private equity fund Abac Solutions and PronoKal Group’s management team have acquired 100 per cent of the company from its founders, in order to support its expansion process in Europe and Latin America.

PronoKal Group makes protein-based dietary treatments for obesity and overweight, with sales in excess of EUR42 million and presence in 15 countries in Europe and Latin America.

The investment by Abac and the management team aims to increase the group’s presence in Europe and Latin America, where obesity is an increasingly widespread disease. PronoKal Group, which will continue to be led by its current management team, will continue research for the development of new treatments and the improvement of the current ones.

Oriol Pinya, founding partner at Abac Capital, says: "We are confident that we can support the management team in accelerating the company's growth through its international expansion, as well as continuing to move towards an increased professionalisation."

Dr Joan Fondevila, PronoKal Group’s CEO and one of the co-investors in the deal, says Abac will be crucial to accelerating the company’s growth, as well as investing in new and better treatments.

Read more on:

Latest news See all

- Abac backs PronoKal MBO [04/06/2017 •]

- Abac Solutions acquires PronoKal Group [04/05/2017 • Private Equity Wire]